Can tirzepatide or semaglutide cause low blood pressure?
Yes. Tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) can cause low blood pressure, but few people get it. In US label trials, it affected 1.6% on Zepbound against 0.1% on placebo. On Wegovy it affected 1.3% against 0.4%. It is more frequent with blood pressure medicines and can come with stomach side effects or dehydration.
How often does low blood pressure happen on these medicines?
In trials reported in US labels for the weight-loss brands, low blood pressure affected about 1 to 2 in 100 people, more than placebo.12
The NHS defines low blood pressure as a reading under 90/60 mmHg.3 The US Zepbound label gives 1.6% on tirzepatide against 0.1% on placebo. That count includes orthostatic hypotension (low blood pressure on standing).1
The US Wegovy label gives 1.3% on semaglutide against 0.4% on placebo. It also reports fainting in 0.8% against 0.2%.2
Dizziness is more frequent. In the US labels, it affected 4% to 5% on Zepbound against 2% on placebo, and 8% on Wegovy 2.4 mg against 4%.12
The UK Mounjaro SmPC (product information) says 94% of hypotension-related events in its weight-management trials were mild to moderate.4 In the SURMOUNT-1 trial, 4 people on tirzepatide (0.2%) had a severe or serious blood-pressure-related event. No one on placebo had a serious one.5
We found no hypotension entry in the US Mounjaro label, the US Ozempic label or the UK Ozempic SmPC.678 That gap is no proof of lower risk.
Who is more likely to get low blood pressure?
People already taking blood pressure medicines are more likely to get low blood pressure, and some cases come with stomach side effects and dehydration.12
In the US Zepbound label, it occurred in 2.2% of people on blood pressure medicines. The rate without them was 1.2%.1 The US Wegovy label also says it was more frequent with those medicines.2
A health-record study at the Endocrine Society's 2026 meeting compared 42,262 adults before and after starting semaglutide, tirzepatide or liraglutide. All took at least two blood pressure medicines.9
Events, which included low readings, fainting, dizziness and falls, rose from 8.7% to 10.2% at 6 months and from 13.6% to 14.3% at 12 months. The change at 24 months was not significant.9
Adults aged 65 and over made up 53% of events but 37% of participants.10 This is a conference report, and we found no full published paper.9 One news report describes 54,682 people and a comparison with non-users.16
How much does blood pressure fall, and how soon?
On average, blood pressure fell in the main tirzepatide trial, and weight loss explained about two-thirds of that fall in a later analysis.5
At 72 weeks in SURMOUNT-1, systolic (top-number) pressure fell 6.8 mmHg more on tirzepatide than on placebo. Diastolic (bottom-number) pressure fell 4.2 mmHg more.5
The fall was quick over the first 24 weeks, then levelled off. Weight loss explained 68% of the systolic fall and 71% of the diastolic fall.5
Blood-pressure-related side effects, dizziness included, occurred in 6.8% on tirzepatide against 3.3% on placebo. Eli Lilly, which makes tirzepatide, sponsored this analysis.5
The UK Wegovy SmPC reports a 6.2 mmHg systolic fall on semaglutide 2.4 mg in STEP 1. On placebo it was 1.1 mmHg.11 That figure is from week 68.11
What helps when you feel dizzy or your readings are low?
The NHS's steps for low blood pressure are rising slowly from sitting to standing, drinking more water and eating small, frequent meals.3
The NHS says low blood pressure does not always cause symptoms, but you may need treatment if it does.3
If you feel about to faint, the NHS says to lie down and raise your legs. If you cannot, sit with your head between your knees.12
Dizziness or light-headedness can also be a symptom of low blood sugar, according to the Zepbound Medication Guide.1
The NHS says a GP may change a medicine or its dose if it is the cause.3 We found no instruction on adjusting blood pressure medicines in the US Zepbound or Wegovy labels.12
What do people on GLP-1 medicines report about low blood pressure?
From public patient forums: 173 Reddit threads in r/Zepbound, r/Semaglutide, r/Mounjaro, r/mounjarouk, r/WegovyPillWeightLoss and r/WegovyWeightLoss, read from October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Matches the label Many describe dizziness or lightheadedness, mostly on standing. US labels list dizziness and blood pressure drops on standing.12
- Matches the label Many say they had low readings or symptoms while on a blood pressure medicine, which was then reduced or stopped, usually by a clinician. US labels report more low blood pressure with those medicines, but do not cover the dose changes.12
- Matches the label Many report fainting, and several report an injury from a faint or fall. These threads were chosen for this topic, so they cannot show how often it happens. The US Wegovy label lists fainting, but not injuries.2
- Matches the UK label Several say symptoms began or worsened after a dose increase. The UK Wegovy SmPC says dizziness was mainly seen during dose increases.11
- Not studied Several say symptoms cluster in the days after an injection. We found no study of that timing.
Advice people share
- Matches the NHS Many suggest more fluids, rising slowly and small, regular meals. These are NHS steps, though several say extra fluids did little or helped only briefly.3
- Matches the NHS Many suggest having blood pressure medicines reviewed as weight falls. The NHS says a GP may change a medicine that is causing low blood pressure. It does not mention weight loss.3
- NHS says otherwise Several suggest large salt or electrolyte increases. The NHS sets a limit of 6 g of salt a day for adults. It says too much can cause high blood pressure.13
- NHS says otherwise Several describe cutting or stopping blood pressure or heart medicines on their own. NHS guidance on bisoprolol, one such medicine, says stopping without medical advice may make the condition worse.14
In your country
The trial figures above come from US labels and UK SmPCs and apply to the medicines themselves, while the brands sold and the labels we could open differ by country.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: We could not open Australia's Product Information, so this page relies on the US labels and UK SmPCs.
Emergency number: 000
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: We could not open Canada's Product Monographs, so this page relies on the US labels and UK SmPCs.
Emergency number: 911
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: We could not open the EU product information used in France, so this page relies on the US labels and UK SmPCs.
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: We could not open the EU product information used in Germany, so this page relies on the US labels and UK SmPCs.
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We did not open an Indian label for this page, so it relies on the US labels and UK SmPCs.
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a Saudi label for this page, so it relies on the US labels and UK SmPCs.
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a UAE label for this page, so it relies on the US labels and UK SmPCs.
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: Unlike the US Mounjaro label, the UK Mounjaro SmPC lists hypotension-related events, from its weight-management trials.46
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The answer above applies.
Emergency number: 911
Contact your prescriber or a doctor right away if nausea, vomiting or diarrhoea does not go away.1 See a doctor if you keep getting dizzy spells.3
Read the full picture
Related questions
Sources
- US Zepbound (tirzepatide) prescribing information and Medication Guide, revised August 2026. Eli Lilly
- US Wegovy (semaglutide) prescribing information, revised June 2026. DailyMed
- NHS. Low blood pressure (hypotension). nhs.uk
- UK Mounjaro KwikPen (tirzepatide) SmPC, last updated on emc 8 September 2026. emc
- Krumholz HM, et al. Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial. Heart. 2024;110(19):1165-1171. PMC11420724
- US Mounjaro (tirzepatide) prescribing information, revised August 2026. Eli Lilly
- US Ozempic (semaglutide) prescribing information, revised May 2026. DailyMed
- UK Ozempic (semaglutide) SmPC, last updated on emc 28 July 2026. emc
- HCPLive. GLP-1 initiation associated with increase in hypotensive events in patients with hypertension, June 2026. hcplive.com
- Northwestern University. GLP-1s tied to elevated risk of low blood pressure episodes such as fainting and dizziness, June 2026. news.northwestern.edu
- UK Wegovy 2.4 mg FlexTouch (semaglutide) SmPC, last updated on emc 22 September 2026. emc
- NHS. Fainting. nhs.uk
- NHS. Salt in your diet. nhs.uk
- NHS. Bisoprolol. nhs.uk
- MedlinePlus, US National Library of Medicine. Recognizing medical emergencies, giving the American College of Emergency Physicians' warning signs. medlineplus.gov
- Healio. GLP-1s linked to elevated rates of hypotensive events, June 2026. healio.com
Last checked Nov 9, 2026 · Next review due Nov 9, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked by Nov 9, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write